» Articles » PMID: 17999182

An Extended Random-effects Approach to Modeling Repeated, Overdispersed Count Data

Overview
Publisher Springer
Date 2007 Nov 14
PMID 17999182
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Non-Gaussian outcomes are often modeled using members of the so-called exponential family. The Poisson model for count data falls within this tradition. The family in general, and the Poisson model in particular, are at the same time convenient since mathematically elegant, but in need of extension since often somewhat restrictive. Two of the main rationales for existing extensions are (1) the occurrence of overdispersion, in the sense that the variability in the data is not adequately captured by the model's prescribed mean-variance link, and (2) the accommodation of data hierarchies owing to, for example, repeatedly measuring the outcome on the same subject, recording information from various members of the same family, etc. There is a variety of overdispersion models for count data, such as, for example, the negative-binomial model. Hierarchies are often accommodated through the inclusion of subject-specific, random effects. Though not always, one conventionally assumes such random effects to be normally distributed. While both of these issues may occur simultaneously, models accommodating them at once are less than common. This paper proposes a generalized linear model, accommodating overdispersion and clustering through two separate sets of random effects, of gamma and normal type, respectively. This is in line with the proposal by Booth et al. (Stat Model 3:179-181, 2003). The model extends both classical overdispersion models for count data (Breslow, Appl Stat 33:38-44, 1984), in particular the negative binomial model, as well as the generalized linear mixed model (Breslow and Clayton, J Am Stat Assoc 88:9-25, 1993). Apart from model formulation, we briefly discuss several estimation options, and then settle for maximum likelihood estimation with both fully analytic integration as well as hybrid between analytic and numerical integration. The latter is implemented in the SAS procedure NLMIXED. The methodology is applied to data from a study in epileptic seizures.

Citing Articles

Istore: a project on innovative statistical methodologies to improve rare diseases clinical trials in limited populations.

Schoenen S, Verbeeck J, Koletzko L, Brambilla I, Kuchenbuch M, Dirani M Orphanet J Rare Dis. 2024; 19(1):96.

PMID: 38431612 PMC: 10909280. DOI: 10.1186/s13023-024-03103-2.


Under-reported time-varying MINAR(1) process for modeling multivariate count series.

Aghabazaz Z, Kazemi I Comput Stat Data Anal. 2023; 188.

PMID: 37700855 PMC: 10493608. DOI: 10.1016/j.csda.2023.107825.


Longitudinal social contact data analysis: insights from 2 years of data collection in Belgium during the COVID-19 pandemic.

Loedy N, Coletti P, Wambua J, Hermans L, Willem L, Jarvis C BMC Public Health. 2023; 23(1):1298.

PMID: 37415096 PMC: 10326964. DOI: 10.1186/s12889-023-16193-7.


Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries.

Lee Y, Lui L, Chen-Li D, Liao Y, Mansur R, Brietzke E J Affect Disord. 2021; 290:364-377.

PMID: 34052584 PMC: 8159271. DOI: 10.1016/j.jad.2021.04.050.


Longitudinal Joint Modelling of Ordinal and Overdispersed Count Outcomes: A Bridge Distribution for the Ordinal Random Intercept.

Amini P, Moghimbeigi A, Zayeri F, Tapak L, Maroufizadeh S, Verbeke G Comput Math Methods Med. 2021; 2021:5521881.

PMID: 33763151 PMC: 7946459. DOI: 10.1155/2021/5521881.


References
1.
Aitkin M . A general maximum likelihood analysis of variance components in generalized linear models. Biometrics. 2001; 55(1):117-28. DOI: 10.1111/j.0006-341x.1999.00117.x. View

2.
Thall P, Vail S . Some covariance models for longitudinal count data with overdispersion. Biometrics. 1990; 46(3):657-71. View

3.
Faught E, Wilder B, Ramsay R, Reife R, Kramer L, Pledger G . Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group. Neurology. 1996; 46(6):1684-90. DOI: 10.1212/wnl.46.6.1684. View